Notably, the inhibition of CDCA2 and CDCA5 activities in lung and gastric adenocarcinoma, respectively, resulted in the downregulation of CCNE1 expression, thereby inhibiting cancer cell proliferation and blocking it in the G1 phase [84, 85]. This evidence concerns the gene CDCA5 and cancer.